Loading ...

erythrocyte membrane-camouflaged doxorubicin-poly(lactic acid) conjugate nanoparticles

Based on

1 Patents
2013 Most recent source

Composition

Image only illustrates the order and placement of components as described in literature.

1

doxorubicin-poly(lactic acid) conjugate

DOX-PLA conjugate
Type Polymer
Formula
Role core
2

red blood cell membrane

RBC membrane RBCm
Type Bioobject
Formula
Role layer

Properties

General physical and chemical properties

Property Value Nanomaterial Variant Source
drug release

More information/entries available to subscribers only.

Or, view sample content

Applications

Area Application Nanomaterial Variant Source
drug delivery

More information available to subscribers only.

Or, view sample content

Biological effects

Biological system Test details Nanomaterial Variant Source
AML Kasumi-1 cells

More information available to subscribers only.

Or, view sample content

Preparation

Method 1

Type: Physical formation
Source:
Product

erythrocyte membrane-camouflaged doxorubicin-poly(lactic acid) conjugate nanoparticles

Size: ~ 90 nm

Medium: phosphate buffer solution

Support: none

Method 2

Type: Physical formation
Source:
Starting materials
Product

erythrocyte membrane-camouflaged doxorubicin-poly(lactic acid) conjugate nanoparticles

Size: ~ 90 nm

Medium/Support: none

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial